# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-007330
Filing Date
2025-01-30
Accepted
2025-01-29 20:16:07
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm2429853d10_defa14a.htm | DEFA14A | 24112
2 | GRAPHIC | tm2429853d10_defa14aimg001.jpg | GRAPHIC | 389781
3 | GRAPHIC | tm2429853d10_defa14aimg002.jpg | GRAPHIC | 172607
4 | GRAPHIC | tm2429853d10_defa14aimg003.jpg | GRAPHIC | 317730
| Complete submission text file | 0001104659-25-007330.txt |  | 1238035

Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 25570774
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)